A team of engineers and neuroscientists at the University of California San Diego (UC San Diego) has developed a groundbreaking wearable device that could make Parkinson's disease treatment safer and more personalized. The researchers have created a soft fingertip patch that continuously measures medication levels through a patient's sweat—without using a battery.
The innovative device, described in the Proceedings of the National Academy of Sciences (PNAS), provides real-time information about the amount of levodopa, the most widely used medicine for Parkinson's disease. The patch delivers results that closely match standard laboratory blood tests while offering continuous monitoring from the comfort of a patient's home.
Experts believe this technology could help doctors prescribe the right dose at the right time, improving symptom control and reducing harmful side effects.
A Major Challenge in Parkinson's Treatment
Parkinson's disease is a progressive neurological disorder that affects movement. It develops when brain cells that produce dopamine gradually die. Dopamine is a chemical messenger that helps control smooth and coordinated muscle movements.
Because dopamine cannot be taken directly as a medicine, patients are treated with levodopa, a drug that the brain converts into dopamine.
Levodopa has been the gold-standard treatment for Parkinson's disease for decades. It helps reduce symptoms such as:
Tremors
Muscle stiffness
Slow movement
Difficulty walking
Poor balance
However, finding the correct dose is one of the biggest challenges in Parkinson's care.
If patients receive too little levodopa, they may suddenly become stiff and unable to move properly.
If they receive too much, they can develop involuntary, uncontrolled body movements known as dyskinesia, which can seriously affect daily life.
Doctors therefore need to carefully balance each patient's medication schedule.
Why Current Monitoring Is Difficult
During the early stages of Parkinson's disease, a single dose of levodopa may control symptoms for several hours.
But as the disease progresses, the medicine wears off much more quickly. In many patients, its beneficial effects may last only around two hours.
This means medication levels can change rapidly throughout the day.
Currently, doctors mainly depend on patients to record their symptoms in handwritten diaries or describe how they felt during clinic visits.
These methods have several limitations.
Patients may forget to record symptoms accurately, overlook important changes, or be unable to identify exactly when their medication stopped working. As a result, doctors often lack precise information when adjusting treatment.
Frequent blood tests could provide more accurate data, but they are inconvenient, expensive, and cannot continuously monitor medication levels throughout the day.
A Small Patch With Big Potential
To solve this problem, researchers designed a soft wearable patch that is placed on the fingertip.
The fingertip is an ideal location because it contains one of the highest concentrations of sweat glands in the human body.
Unlike many wearable health devices, this patch does not need a battery or external power source.
Instead, it uses the patient's own sweat to operate.
This unique design makes the device lightweight, comfortable, and suitable for continuous wear.
How the Patch Works
The patch contains a specially engineered absorbent gel that works like a tiny sweat sponge.
The gel is filled with a concentrated mixture of harmless salts and safe solvents. Because water naturally moves toward areas with higher salt concentrations, the gel gently draws sweat from the skin without requiring physical activity or exercise.
As sweat enters the patch, it carries tiny amounts of levodopa.
Inside the device are special enzymes that react with the levodopa molecules.
This chemical reaction produces a small electrical voltage.
Remarkably, this same reaction performs two jobs at once:
It generates the electricity needed to power the patch.
It measures the amount of levodopa in the sweat.
A higher voltage indicates higher levodopa levels, while a lower voltage signals that medication levels have fallen.
Because the device continuously measures these changes, it provides a real-time picture of how the medicine moves through the body.
Clinical Tests Show Promising Results
The research team tested the wearable device in both healthy volunteers and people living with Parkinson's disease.
The results were highly encouraging.
The fingertip patch measured levodopa levels with accuracy comparable to standard laboratory blood tests.
However, unlike traditional blood tests—which may require days before results become available—the wearable patch delivers continuous information in real time.
This immediate feedback could allow doctors to adjust medication schedules much faster and more accurately.
A Surprising Discovery
During the clinical study, researchers made another important observation.
People with Parkinson's disease cleared levodopa from their bodies much faster than healthy individuals.
This finding helps explain why many patients experience sudden changes in symptoms after taking their medication.
As drug levels fall rapidly, patients may quickly transition from moving normally to experiencing stiffness, slowed movement, or difficulty walking.
Understanding this faster drug clearance could help doctors design better treatment schedules that maintain more stable medication levels throughout the day.
Towards Truly Personalized Parkinson's Care
One of the most exciting aspects of this technology is its potential to support personalized medicine.
Every Parkinson's patient responds differently to levodopa. Factors such as age, disease progression, metabolism, and overall health affect how long the medication remains effective.
Instead of relying on fixed dosing schedules, doctors could use continuous measurements from the patch to customize medication timing for each individual patient.
This approach could reduce periods when symptoms return unexpectedly while also lowering the risk of side effects caused by excessive medication.
The Future: An Automatic Drug Delivery System
Researchers believe this wearable sensor is only the beginning.
In the future, the monitoring patch could become part of a closed-loop treatment system.
In such a system, the patch would continuously monitor levodopa levels and communicate directly with a wearable drug pump.
Whenever medication levels begin to fall below the desired range, the pump could automatically deliver the exact amount of levodopa needed.
This would create an intelligent treatment system that responds to each patient's changing needs throughout the day with little or no manual intervention.
Although more research and larger clinical trials are needed before this technology reaches hospitals and homes, the concept represents a major step toward automated Parkinson's care.
A Collaborative Scientific Achievement
The project was led by Tamoghna Saha, a postdoctoral researcher in the laboratory of Professor Joseph Wang at the UC San Diego Jacobs School of Engineering.
The engineering team worked closely with the laboratory of Professor Irene Litvan from the UC San Diego School of Medicine, combining expertise in engineering, chemistry, and neuroscience.
This interdisciplinary collaboration allowed researchers to develop a device that bridges medical science and wearable technology.
Looking Ahead
Parkinson's disease affects millions of people worldwide, and managing medication remains one of the greatest challenges for patients and healthcare providers.
The new battery-free fingertip patch offers a promising solution by continuously tracking levodopa levels through sweat with laboratory-level accuracy.
If future studies confirm its effectiveness, the technology could replace subjective symptom diaries with objective, real-time data, helping doctors make faster and more precise treatment decisions.
Beyond Parkinson's disease, this breakthrough also highlights the growing potential of wearable biosensors that use the body's own chemistry to monitor health without needles, batteries, or frequent hospital visits.
As wearable medical technologies continue to advance, devices like this fingertip patch could play a major role in making healthcare more personalized, convenient, and effective for millions of patients around the world.
Reference:
A wearable patch for continuous levodopa monitoring in sweat: Towards exertion and power-free pharmacodynamic assessment in Parkinson’s disease, Proc. Natl. Acad. Sci. U.S.A. 123 (32) e2610453123, https://doi.org/10.1073/pnas.2610453123 (2026).
Comments
Post a Comment